OUTPATIENT MYOSURE - STUDY OF TRENDS AND PATIENT PERSPECTIVE

Introduction

Outpatient hysteroscopy service offers a safe, convenient and cost effective means of diagnosing and treating abnormal uterine bleeding; and aiding the management of other benign gynaecological conditions.

 MyoSure tissue removal system is intended to remove unwanted tissue (eg polyp, fibroid) from the uterus.

Objectives

To collect data on the number of outpatient MyoSure procedures performed at DPOW from January 2020 to January 2022.

To analyse the common types of lesions for which MyoSure procedures were performed.

To collect data on pain scores for the procedures and assess the need for optimising pain relief methods so as to increase the acceptability of the procedure

Method

We examined the clinic's standardised paper form, which records data  procedures, supplies used, and pain management. We tracked patient outcomes using our organisation's Electronic Health Records (WEBV) system

Results

We studied 131 ambulatory patients. Age group: 40-49; 33.6% (44/131), 50-59: 34.4% (45/131); Parity ³1,70.8% (92/131), indications include endometrial polyp 70%, submucous fibroid 24%, fibroid polyp 5%, and adhesions 1%.Like pain scores 0-5 (mild) in 33.9% (22/62), 6-7 (moderate): 29% (18/62), 8- 10 (severe) 3.2% (2/62). Devices: Reach 48.8% (64/131), MyoSure Lite 34.4% (445/131), MyoSure XL 9% (12), MyoSure manual 7.6% (10).

We did not register any procedural complications.

Before the procedure, all patients received simple analgesics and a cervical block, with a Health Care Assistant present throughout the treatment.

Most patients reported no or minimal pain and did not require additional analgesia.

One-third of the patients experienced moderate pain but could complete the procedure.

Only two of the sixty two documented patients experienced severe pain. There was no correlation between the severity of pain and age, parity, lesion type, or device type.

Summary